Total Payments
$24,144
2024 Payments
$902.63
Companies
43
Transactions
438
Medicare Patients
7,616
Medicare Billing
$1.1M
Payment Breakdown by Category
Other$10,600 (43.9%)
Education$6,744 (27.9%)
Food & Beverage$6,023 (24.9%)
Travel$777.03 (3.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $10,600 | 10 | 43.9% |
| Education | $6,744 | 22 | 27.9% |
| Food and Beverage | $6,023 | 399 | 24.9% |
| Travel and Lodging | $777.03 | 7 | 3.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $11,378 | 47 | $0 (2024) |
| INTUITIVE SURGICAL, INC. | $7,175 | 11 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $907.75 | 63 | $0 (2021) |
| Insmed, Inc. | $692.84 | 36 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $630.81 | 63 | $0 (2024) |
| GlaxoSmithKline, LLC. | $522.38 | 50 | $0 (2023) |
| Grifols USA, LLC | $506.69 | 38 | $0 (2024) |
| Genentech USA, Inc. | $237.13 | 15 | $0 (2024) |
| Ethicon Inc. | $217.38 | 1 | $0 (2022) |
| Astellas Pharma US Inc | $183.90 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $902.63 | 32 | INTUITIVE SURGICAL, INC. ($319.00) |
| 2023 | $7,194 | 29 | Intuitive Surgical, Inc. ($6,732) |
| 2022 | $707.50 | 24 | Ethicon Inc. ($217.38) |
| 2021 | $278.14 | 20 | Boehringer Ingelheim Pharmaceuticals, Inc. ($51.35) |
| 2020 | $660.15 | 42 | Insmed, Inc. ($222.19) |
| 2019 | $4,134 | 73 | AstraZeneca Pharmaceuticals LP ($3,217) |
| 2018 | $7,066 | 105 | AstraZeneca Pharmaceuticals LP ($5,999) |
| 2017 | $3,201 | 113 | AstraZeneca Pharmaceuticals LP ($2,014) |
All Payment Transactions
438 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | Merck Sharp & Dohme LLC | CAPVAXIVE (Biological) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: VACCINE | ||||||
| 11/13/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $25.76 | General |
| Category: Respiratory | ||||||
| 11/02/2024 | Siemens Medical Solutions USA, Inc. | Cios Spin (Device) | Food and Beverage | In-kind items and services | $26.45 | General |
| Category: AT - Mobile interventional x-ray/angiography fluoroscopy | ||||||
| 10/15/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $25.99 | General |
| Category: Respiratory | ||||||
| 10/08/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $10.95 | General |
| Category: Respiratory | ||||||
| 09/17/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 09/09/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: Inflammation | ||||||
| 08/20/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $23.67 | General |
| Category: Respiratory | ||||||
| 08/14/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $8.22 | General |
| Category: Respiratory | ||||||
| 08/13/2024 | Galvanize Therapeutics, Inc | ALIYA SYSTEM (Device) | Food and Beverage | In-kind items and services | $36.43 | General |
| Category: PULSED ELECTRIC FIELD | ||||||
| 08/06/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Education | In-kind items and services | $319.00 | General |
| Category: SURGERY | ||||||
| 07/25/2024 | Boston Scientific Corporation | EkoSonic (Device) | Food and Beverage | In-kind items and services | $32.74 | General |
| Category: EkoSonic_PI | ||||||
| 07/11/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $31.03 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 07/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ARALAST (Biological) | Food and Beverage | In-kind items and services | $20.66 | General |
| Category: IMMUNOLOGY | ||||||
| 06/11/2024 | Baxter Healthcare | Hillrom - Monarch Airway Clearance System (Device) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: Airway Clearance Device | ||||||
| 05/31/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: Respiratory | ||||||
| 05/08/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: Oncology | ||||||
| 05/08/2024 | Baxter Healthcare | Hillrom - Monarch Airway Clearance System (Device) | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: Airway Clearance Device | ||||||
| 04/19/2024 | Siemens Medical Solutions USA, Inc. | Cios Spin (Device) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: AT - Mobile interventional x-ray/angiography fluoroscopy | ||||||
| 04/15/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: Respiratory | ||||||
| 04/15/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $3.22 | General |
| Category: Respiratory | ||||||
| 04/11/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: Pulmonology | ||||||
| 04/04/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 03/18/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Respiratory | ||||||
| 03/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 33 | 1,895 | 2,576 | $633,673 | $221,987 |
| 2022 | 28 | 1,857 | 2,732 | $675,311 | $229,860 |
| 2021 | 27 | 1,688 | 2,800 | $833,056 | $286,928 |
| 2020 | 29 | 2,176 | 3,465 | $1.0M | $326,061 |
Total Patients
7,616
Total Services
11,573
Medicare Billing
$1.1M
Procedure Codes
117
All Medicare Procedures & Services
117 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 206 | 458 | $192,818 | $74,571 | 38.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 246 | 523 | $104,077 | $47,791 | 45.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 106 | 112 | $42,448 | $14,855 | 35.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 156 | 205 | $28,085 | $12,326 | 43.9% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 38 | 38 | $20,140 | $10,677 | 53.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 106 | 121 | $29,403 | $10,010 | 34.0% |
| 31645 | Aspiration of initial secretion of lung airway using an endoscope | Facility | 2023 | 87 | 96 | $30,624 | $6,592 | 21.5% |
| 32555 | Aspiration of fluid from chest cavity using imaging guidance | Facility | 2023 | 53 | 62 | $15,960 | $5,188 | 32.5% |
| 31629 | Needle biopsy of windpipe cartilage, airway, and/or lung using an endoscope | Facility | 2023 | 32 | 37 | $15,022 | $5,105 | 34.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 29 | 35 | $12,005 | $4,392 | 36.6% |
| 31652 | Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 1-2 lymph nodes | Facility | 2023 | 31 | 31 | $14,942 | $3,612 | 24.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 24 | 24 | $7,632 | $2,762 | 36.2% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2023 | 21 | 33 | $6,996 | $2,739 | 39.1% |
| 31627 | Computer-assisted image-guided navigation of lung airways using an endoscope | Facility | 2023 | 33 | 37 | $7,807 | $2,714 | 34.8% |
| 31653 | Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 3 or more lymph nodes | Facility | 2023 | 14 | 15 | $8,010 | $2,513 | 31.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 12 | 12 | $5,052 | $1,835 | 36.3% |
| 31654 | Exam of lung airways with diagnostic or therapeutic procedure on growths using an endoscope and ultrasound | Facility | 2023 | 32 | 35 | $5,110 | $1,755 | 34.3% |
| 31628 | Biopsy of lobe of lung using an endoscope, 1 lobe | Facility | 2023 | 39 | 43 | $16,469 | $1,713 | 10.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 26 | 26 | $4,472 | $1,427 | 31.9% |
| 31500 | Emergent insertion of breathing tube into windpipe using an endoscope | Facility | 2023 | 11 | 11 | $3,421 | $1,202 | 35.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 16 | 16 | $2,324 | $1,137 | 48.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 39 | 39 | $2,184 | $1,115 | 51.1% |
| 36556 | Insertion of non-tunneled central venous tube for infusion (5 years or older) | Facility | 2023 | 16 | 17 | $3,145 | $1,103 | 35.1% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2023 | 105 | 118 | $34,338 | $935.61 | 2.7% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 95 | 96 | $2,304 | $846.79 | 36.8% |
About Aaron Mulhall
Aaron Mulhall is a Pulmonary Disease healthcare provider based in Elizabethtown, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/21/2010. The National Provider Identifier (NPI) number assigned to this provider is 1801113576.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Aaron Mulhall has received a total of $24,144 in payments from pharmaceutical and medical device companies, with $902.63 received in 2024. These payments were reported across 438 transactions from 43 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($10,600).
As a Medicare-enrolled provider, Mulhall has provided services to 7,616 Medicare beneficiaries, totaling 11,573 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 117 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Elizabethtown, KY
- Active Since 04/21/2010
- Last Updated 05/20/2016
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1801113576
Products in Payments
- BEVESPI AEROSPHERE (Drug) $7,952
- Da Vinci Surgical System (Device) $4,175
- ION (Device) $3,000
- DALIRESP (Drug) $1,804
- SYMBICORT (Drug) $1,453
- Arikayce (Drug) $676.60
- Utibron (Drug) $345.64
- Prolastin-C Liquid (Biological) $306.63
- LONHALA MAGNAIR (Drug) $289.25
- OFEV (Drug) $276.45
- Monarch Platform (Device) $217.38
- Prolastin-C (Biological) $200.06
- STIOLTO RESPIMAT (Drug) $192.83
- TRELEGY ELLIPTA (Drug) $159.88
- NUCALA (Biological) $158.62
- ANORO (Drug) $157.75
- BROVANA (Drug) $136.67
- Xolair (Biological) $128.44
- ELIQUIS (Drug) $120.12
- UTIBRON (Drug) $116.52
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.